3272: Coronavirus Essential | Delhi HC asks Serum Institute, Bharat Biotech to disclose vaccine manufacturing capacity; overcrowding at vaccination centres a new concern

3271: D-Street Talk | Small & Midcaps will continue to shine on economic recovery, says Ajay Garg of Equirus Capital

3270: Simply Save | Women should take charge of personal and household money matters: Jyoti Vaswani

3268: Hot Stocks: City Union, MCX & Amara Raja batteries among top buy ideas

3269: Coronavirus Essential | Covaxin phase 3 trials efficacy at 81%, says Bharat Biotech; France looking to secure the Indian vaccine

3267: Future Wise | WFH too tiring? Here are lessons you can learn from Infosys

3266: Hot Stocks | L&T Technology Services, Nippon Life India Asset Management, Aarti Industries can give up to 13% return in short term

3265: Coronavirus Essential | 25 lakh people register on Co-WIN portal on day 1 of rollout; Harsh Vardhan, Ravi Shastri and India Inc CEOs get COVID-19 vaccine shots

3264: Hot Stocks | Dalmia Bharat Sugar, Torrent Power, NMDC are 3 short-term trading ideas

3263: Coronavirus Essential | PM Modi receives first dose of Covaxin; CoWin app glitches slow vaccine rollout

3262: Hot Stocks | NTPC, Bajaj Finance, ICICI Bank three trading ideas for short term

3261: Corporate Buzz | Wipro stuck in Citibank's $900 million trouble; vaccines come to private hospitals; Should India too make Google, FB pay for news?

3260: Coronavirus Essential | No vaccinations this weekend due to CoWIN updates; Home Ministry extends existing COVID-19 guidelines till March 31

3259: The Market Podcast | Private sector banks likely to get rerated post FM announcement: Gaurav Garg of CapitalVia Global Research

3258: Hot Stocks | Why Tata Power, Rain Industries and HDFC Bank are bets for short term

3257: Coronavirus Essential | 229 school hostel students test positive in Maharashtra; Pfizer vaccine could help end pandemic, says study

3256: Macro Minutes | Will mega-investment plans drive Indian Railways to a bright future?

3255: D-Street Talk | 'Tech issues cannot be completely avoided given the technological environment'

3254: Coronavirus Essential | Vaccinations for 60-plus group, people with comorbidities from March 1; more 'Made in India' vaccines on the way

3253: D-Street Talk | Possible to make a backup exchange to safeguard traders in times of glitch: Dipan Mehta